Latest Insider Transactions at Allarity Therapeutics, Inc. (ALLR)
This section provides a real-time view of insider transactions for Allarity Therapeutics, Inc. (ALLR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allarity Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allarity Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2025
|
Jeremy R. Graff Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,613
-37.0%
|
$14,613
$1.58 P/Share
|
|
Sep 30
2025
|
Jeremy R. Graff Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,494
+50.0%
|
-
|
|
Jan 22
2025
|
Thomas Jensen CEO |
BUY
Grant, award, or other acquisition
|
Direct |
396,734
+50.0%
|
-
|
|
Jan 22
2025
|
Alexander Epshinsky CFO |
BUY
Grant, award, or other acquisition
|
Direct |
29,496
+25.75%
|
-
|
|
Jan 22
2025
|
Jeremy R. Graff Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144,441
+35.46%
|
-
|
|
Sep 30
2024
|
Jeremy R. Graff Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,483
+50.0%
|
$236,966
$2.11 P/Share
|